G. Gandon

发表

A YAC contig and an STS map spanning at least 3.9 megabasepairs telomeric to HLA-A

J. Mosser, V. David, A. Hampe, 1997, Immunogenetics.

Safety, Pharmacokinetic, and Pharmacodynamic Evaluations of PI‐2301, a Potent Immunomodulator, in a First‐in‐Human, Single‐Ascending‐Dose Study in Healthy Volunteers

A. Patat, N. Fauchoux, E. Zanelli, 2011, Journal of clinical pharmacology.

Clinical and family studies in genetic hemochromatosis: Microsatellite and HFE studies in five atypical families

V. David, J. Legall, P. Adams, 1997, Hepatology.

Prevalence of the C282Y mutation in Brittany: penetrance of genetic hemochromatosis?

P. Fergelot, J. L. Le Gall, Y. Deugnier, 1998, Annales de genetique.

A highly informative dinucleotide repeat polymorphism telomeric to HLA-F

J. Mosser, A. Jouanolle, G. Gandon, 1997, Immunogenetics.

Dinucleotide repeat polymorphism at the D6S510 locus.

V. Lelaure, J. L. Le Gall, V. David, 1994, Human molecular genetics.

Linkage disequilibrium and extended haplotypes in the HLA-A to D6S105 region: implications for mapping the hemochromatosis gene (HFE)

B. Chauvel, J. Yaouanq, J. Feingold, 2004, Human Genetics.

Haemochromatosis and HLA–H

P. Fergelot, J. Mosser, I. Gicquel, 1996, Nature Genetics.

A candidate gene for hemochromatosis: frequency of the C282Y and H63D mutations

P. Fergelot, J. Yaouanq, V. David, 1997, Human Genetics.

Sentinel lymph node analysis in breast cancer: contribution of one-step nucleic acid amplification (OSNA)

V. Quillien, V. Lavoué, H. Mesbah, 2011, Breast Cancer Research and Treatment.